Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | %Female (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
131 | Advances in Antiviral Drug Design | book series | 0.480 Q1 | 12 | 0 | 7 | 0 | 7 | 5 | 0.00 | 0.00 | 0.00 | |
130 | American Journal of PharmacoGenomics | journal | 0.286 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
129 | American Journal of Respiratory Medicine | journal | 34 | 51 | 0 | 3419 | 0 | 0 | 0.00 | 67.04 | 30.00 | ||
128 | Autonomic and Autacoid Pharmacology | journal | 0.281 Q3 | 24 | 35 | 0 | 1360 | 0 | 0 | 0.00 | 38.86 | 34.48 | |
127 | Chemical Speciation and Bioavailability | journal | 0.313 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
126 | Current Drug Discovery | journal | 13 | 174 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 18.18 | ||
125 | Drugs in R and D | journal | 0.176 Q3 | 54 | 89 | 240 | 1238 | 68 | 240 | 0.00 | 13.91 | 30.77 | |
124 | EPC - European Pharmaceutical Contractor | journal | 3 | 95 | 0 | 213 | 0 | 0 | 0.00 | 2.24 | 18.92 | ||
123 | Expert Review of Vaccines | journal | 105 | 57 | 0 | 3050 | 0 | 0 | 0.00 | 53.51 | 28.97 | ||
122 | Journal of Applied Therapeutic Research | journal | 0.108 Q4 | 8 | 0 | 28 | 0 | 3 | 28 | 0.00 | 0.00 | 0.00 | |
121 | Journal of Negative Results in BioMedicine | journal | 25 | 3 | 0 | 34 | 0 | 0 | 0.00 | 11.33 | 0.00 | ||
120 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 0 | 1590 | 0 | 3 | 118 | 0.00 | 0.00 | 0.00 | |
119 | Nature Reviews Drug Discovery | journal | 391 | 232 | 0 | 7326 | 0 | 0 | 0.00 | 31.58 | 18.18 | ||
118 | Pharmacy and Pharmacology Communications | journal | 0.242 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
117 | Pharmacy in Practice | journal | 0.100 Q4 | 6 | 21 | 64 | 222 | 0 | 46 | 0.00 | 10.57 | 31.82 | |
116 | Toxic Substance Mechanisms | journal | 0.159 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
115 | Toxicology Methods | journal | 0.186 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
114 | Tumor Targeting | journal | 0.384 Q2 | 10 | 0 | 32 | 0 | 35 | 31 | 0.00 | 0.00 | 0.00 | |
113 | Quality Assurance Journal | journal | 0.100 Q4 | 11 | 29 | 60 | 72 | 1 | 51 | 0.02 | 2.48 | 56.52 | |
112 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 0 | 125 | 0 | 2 | 67 | 0.03 | 0.00 | 0.00 | |
111 | Prescribers' Journal | journal | 0.108 Q4 | 6 | 0 | 73 | 0 | 7 | 56 | 0.03 | 0.00 | 0.00 | |
110 | Pharmaceutical Journal | journal | 0.208 Q2 | 28 | 2882 | 1642 | 1404 | 124 | 572 | 0.06 | 0.49 | 42.21 | |
109 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 6 | 14 | 68 | 1 | 9 | 0.07 | 11.33 | 50.00 | |
108 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.112 Q4 | 8 | 0 | 49 | 0 | 4 | 47 | 0.08 | 0.00 | 0.00 | |
107 | Hospital Pharmacist | journal | 13 | 85 | 117 | 887 | 14 | 92 | 0.12 | 10.44 | 49.23 | ||
106 | Pharmaceutical News | journal | 0.125 Q3 | 11 | 66 | 101 | 1467 | 13 | 87 | 0.13 | 22.23 | 14.29 | |
105 | DARU, Journal of Pharmaceutical Sciences | journal | 0.155 Q3 | 58 | 33 | 28 | 582 | 4 | 28 | 0.14 | 17.64 | 28.28 | |
104 | Cutaneous and Ocular Toxicology | journal | 0.111 Q4 | 37 | 24 | 140 | 971 | 11 | 122 | 0.15 | 40.46 | 26.00 | |
103 | Pharmaceutical Medicine | journal | 0.162 Q3 | 25 | 30 | 203 | 405 | 38 | 130 | 0.17 | 13.50 | 13.46 | |
102 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.254 Q3 | 5 | 0 | 35 | 0 | 10 | 30 | 0.29 | 0.00 | 0.00 | |
101 | Pharmaceutical Biology | journal | 0.321 Q2 | 88 | 113 | 258 | 2868 | 106 | 257 | 0.31 | 25.38 | 34.60 | |
100 | Paediatric and Perinatal Drug Therapy | journal | 0.193 Q3 | 20 | 13 | 45 | 427 | 17 | 39 | 0.34 | 32.85 | 33.33 | |
99 | Pharmacology Reviews and Communications | journal | 0.204 Q3 | 9 | 23 | 59 | 754 | 26 | 59 | 0.35 | 32.78 | 27.94 | |
98 | Toxicology Mechanisms and Methods | journal | 0.121 Q4 | 55 | 23 | 98 | 679 | 45 | 96 | 0.39 | 29.52 | 37.33 | |
97 | Journal of Asian Natural Products Research | journal | 0.272 Q2 | 51 | 49 | 112 | 529 | 43 | 112 | 0.43 | 10.80 | 32.94 | |
96 | International Journal of Geriatric Psychopharmacology | journal | 0.208 Q3 | 11 | 0 | 29 | 0 | 12 | 28 | 0.44 | 0.00 | 0.00 | |
95 | IDrugs : the investigational drugs journal | journal | 0.172 Q3 | 39 | 177 | 306 | 2303 | 84 | 302 | 0.46 | 13.01 | 30.00 | |
94 | International Journal of Pharmacy Practice | journal | 0.424 Q1 | 44 | 37 | 116 | 894 | 80 | 112 | 0.49 | 24.16 | 59.41 | |
93 | Journal of Food Biochemistry | journal | 0.467 Q2 | 64 | 34 | 108 | 1033 | 71 | 108 | 0.51 | 30.38 | 27.72 | |
92 | Toxicology and Industrial Health | journal | 0.497 Q2 | 69 | 44 | 142 | 1842 | 232 | 138 | 0.52 | 41.86 | 31.79 | |
91 | Current Opinion in Investigational Drugs | journal | 0.392 Q2 | 83 | 235 | 36 | 11722 | 21 | 33 | 0.58 | 49.88 | 22.66 | |
90 | International Journal of Cosmetic Science | journal | 0.211 Q2 | 77 | 40 | 125 | 905 | 73 | 119 | 0.59 | 22.63 | 36.84 | |
89 | Comments on Toxicology | journal | 0.231 Q3 | 13 | 27 | 45 | 1001 | 17 | 33 | 0.60 | 37.07 | 46.51 | |
88 | Pharmacology and Toxicology, Supplement | journal | 0.262 Q3 | 7 | 0 | 11 | 0 | 6 | 10 | 0.60 | 0.00 | 0.00 | |
87 | Journal of Clinical Research | journal | 0.733 Q2 | 12 | 2 | 30 | 22 | 14 | 30 | 0.63 | 11.00 | 0.00 | |
86 | Mathematical Medicine and Biology | journal | 0.394 Q2 | 49 | 15 | 58 | 399 | 38 | 58 | 0.63 | 26.60 | 11.54 | |
85 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.330 Q3 | 25 | 19 | 61 | 1078 | 53 | 29 | 0.65 | 56.74 | 47.73 | |
84 | Acta Pharmacologica Sinica | journal | 0.331 Q3 | 117 | 225 | 645 | 4294 | 502 | 644 | 0.73 | 19.08 | 31.54 | |
83 | International Antiviral News | journal | 0.295 Q3 | 8 | 0 | 75 | 0 | 36 | 52 | 0.73 | 0.00 | 0.00 | |
82 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.338 Q3 | 67 | 67 | 185 | 1715 | 160 | 182 | 0.73 | 25.60 | 30.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®